Submit Deal

TRANSCEND THERAPEUTICS

Summary

Transcend Therapeutics offers novel pharmaceuticals for the critical care market.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 33 M

Avg. Deal Size£ 33 M

Market Context

Senior Management

Senior Management

Sort

kevin ryan

Co-Founder and Chairman at TRANSCEND THERAPEUTICS

Manager

Deal

£ 33 M

Total Value

blake mandell

Co-Founder and CEO at TRANSCEND THERAPEUTICS

Manager

Deal

£ 33 M

Total Value

martin stogniew

Chief Development Officer at TRANSCEND THERAPEUTICS

Manager

Deal

£ 33 M

Total Value

amanda jones

Senior Vice President of Clinical Development at TRANSCEND THERAPEUTICS

Manager

Deal

£ 33 M

Total Value

ben kelmendi

Co-Founder and Chief Scientific Advisor at TRANSCEND THERAPEUTICS

Manager

Deal

£ 33 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy